Discovery of Some of the Biological Effects of Nitric Oxide and its Role in Cell Signaling

[1]  Richard G. W. Anderson,et al.  Acylation Targets Endothelial Nitric-oxide Synthase to Plasmalemmal Caveolae (*) , 1996, The Journal of Biological Chemistry.

[2]  T. Michel,et al.  Oligomerization of Endothelial Nitric Oxide Synthase , 1995, The Journal of Biological Chemistry.

[3]  F. Murad,et al.  Two closely linked but separable promoters for human neuronal nitric oxide synthase gene transcription. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[4]  T. Michel,et al.  Agonist-modulated Palmitoylation of Endothelial Nitric Oxide Synthase (*) , 1995, The Journal of Biological Chemistry.

[5]  F. Murad,et al.  Endothelial nitric oxide synthase is myristylated , 1992, FEBS letters.

[6]  F. Murad,et al.  Purification and characterization of particulate endothelium-derived relaxing factor synthase from cultured and native bovine aortic endothelial cells. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[7]  F. Murad,et al.  Phosphorylation by calcium calmodulin-dependent protein kinase II and protein kinase C modulates the activity of nitric oxide synthase. , 1991, Biochemical and biophysical research communications.

[8]  F. Murad,et al.  Isoforms of nitric oxide synthase. Characterization and purification from different cell types. , 1991, Biochemical pharmacology.

[9]  C. Nathan,et al.  Purification and characterization of the cytokine-induced macrophage nitric oxide synthase: an FAD- and FMN-containing flavoprotein. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[10]  F. Murad,et al.  Purification of a soluble isoform of guanylyl cyclase-activating-factor synthase. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[11]  F. Murad,et al.  Hormone-induced biosynthesis of endothelium-derived relaxing factor/nitric oxide-like material in N1E-115 neuroblastoma cells requires calcium and calmodulin. , 1990, Molecular pharmacology.

[12]  F. Murad,et al.  Subcellular localization and regulation of the enzymes responsible for EDRF synthesis in endothelial cells and N1E-115 neuroblastoma cells , 1990 .

[13]  F. Murad,et al.  Production of an EDRF‐like activity in the cytosol of N1E‐115 neuroblastoma cells , 1990, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[14]  F. Murad,et al.  Mechanism of cyclic GMP inhibition of inositol phosphate formation in rat aorta segments and cultured bovine aortic smooth muscle cells. , 1990, The Journal of biological chemistry.

[15]  F. Murad,et al.  The cytosol of N1E-115 neuroblastoma cells synthesizes an EDRF-like substance that relaxes rabbit aorta , 1989, Naunyn-Schmiedeberg's Archives of Pharmacology.

[16]  F. Murad.  Role of cyclic GMP in the mechanism of action of nitrovasodilators, endothelium-dependent agents and atrial natriuretic peptide. , 1988, Biochemical Society transactions.

[17]  F. Murad,et al.  Cyclic GMP synthesis and function. , 1987, Pharmacological reviews.

[18]  J. Hibbs,et al.  Macrophage cytotoxicity: role for L-arginine deiminase and imino nitrogen oxidation to nitrite. , 1987, Science.

[19]  F. Murad,et al.  Cyclic guanosine monophosphate as a mediator of vasodilation. , 1986, The Journal of clinical investigation.

[20]  F. Murad,et al.  Co-purification of an atrial natriuretic factor receptor and particulate guanylate cyclase from rat lung. , 1986, The Journal of biological chemistry.

[21]  F. Murad,et al.  Atrial natriuretic factor selectively activates particulate guanylate cyclase and elevates cyclic GMP in rat tissues. , 1984, The Journal of biological chemistry.

[22]  F. Murad,et al.  Atrial natriuretic factor elicits an endothelium-independent relaxation and activates particulate guanylate cyclase in vascular smooth muscle. , 1984, Proceedings of the National Academy of Sciences of the United States of America.

[23]  F. Murad,et al.  Effect of cyanide on nitrovasodilator-induced relaxation, cyclic GMP accumulation and guanylate cyclase activation in rat aorta. , 1984, European journal of pharmacology.

[24]  K. Alitalo,et al.  Identification of nuclear proteins encoded by viral and cellular myc oncogenes , 1983, Nature.

[25]  Robert M. Rapoport,et al.  Endothelium-dependent relaxation in rat aorta may be mediated through cyclic GMP-dependent protein phosphorylation , 1983, Nature.

[26]  F. Murad,et al.  Agonist‐Induced Endothelium‐Dependent Relaxation in Rat Thoracic Aorta May Be Mediated through cGMP , 1983, Circulation research.

[27]  F. Murad,et al.  Sodium nitroprusside-induced protein phosphorylation in intact rat aorta is mimicked by 8-bromo cyclic GMP. , 1982, Proceedings of the National Academy of Sciences of the United States of America.

[28]  T. Deguchi,et al.  L-Arginine identified as an endogenous activator for soluble guanylate cyclase from neuroblastoma cells. , 1982, The Journal of biological chemistry.

[29]  R. Furchgott,et al.  The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine , 1980, Nature.

[30]  F. Murad,et al.  Effects of sodium nitroprusside, nitroglycerin, and sodium azide on levels of cyclic nucleotides and mechanical activity of various tissues. , 1977, Journal of cyclic nucleotide research.

[31]  F. Murad,et al.  Nitric oxide activates guanylate cyclase and increases guanosine 3':5'-cyclic monophosphate levels in various tissue preparations. , 1977, Proceedings of the National Academy of Sciences of the United States of America.

[32]  F. Murad,et al.  Purification and properties of a protein required for sodium azide activation of guanylate cyclase. , 1977, The Journal of biological chemistry.

[33]  F. Murad,et al.  Regulation of adenosine cyclic 3',5'-monophosphate and guanosine cyclic 3',5'-monophosphate levels and contractility in bovine tracheal smooth muscle. , 1977, Molecular pharmacology.

[34]  F. Murad,et al.  Stimulation of guanylate cyclase by sodium nitroprusside, nitroglycerin and nitric oxide in various tissue preparations and comparison to the effects of sodium azide and hydroxylamine. , 1977, Journal of cyclic nucleotide research.

[35]  F. Murad,et al.  Appearance of magnesium guanylate cyclase activity in rat liver with sodium azide activation. , 1976, The Journal of biological chemistry.

[36]  F. Murad,et al.  Activation of guanylate cyclase from rat liver and other tissues by sodium azide. , 1975, The Journal of biological chemistry.

[37]  F. Murad,et al.  Increases in cyclic GMP levels in brain and liver with sodium azide an activator of guanylate cyclase , 1975, Nature.

[38]  F. Murad,et al.  Increased particulate and decreased soluble guanylate cyclase activity in regenerating liver, fetal liver, and hepatoma. , 1975, Proceedings of the National Academy of Sciences of the United States of America.

[39]  F. Murad,et al.  Two forms of guanylate cyclase in mammalian tissues and possible mechanisms for their regulation. , 1975, Metabolism: clinical and experimental.

[40]  F. Murad,et al.  Evidence for two different forms of guanylate cyclase in rat heart. , 1974, The Journal of biological chemistry.

[41]  W. D. Patterson,et al.  THE FORMATION AND METABOLISM OF CYCLIC GMP * , 1971, Annals of the New York Academy of Sciences.

[42]  F. Murad,et al.  Effects of lipolytic and antilipolytic agents on cyclic 3',5'-adenosine monophosphate in fat cells. , 1971, The Journal of biological chemistry.

[43]  F. Murad,et al.  Effects of guanosine 3',5'-monophosphate on glycerol production and accumulation of adenosine 3',5'-monophosphate by fat cells. , 1970, The Journal of biological chemistry.

[44]  F. Murad,et al.  Adenyl cyclase activity in particles from fat cells. , 1969, Biochemistry.

[45]  F. Murad,et al.  Nitric oxide : biochemistry, molecular biology, and therapeutic implications , 1995 .

[46]  F. Murad.  Cyclic GMP : synthesis, metabolism, and function , 1994 .

[47]  F. Murad.  Introduction and Some Historical Comments , 1994 .

[48]  Michael Chinkers,et al.  Signal transduction by guanylyl cyclases. , 1991, Annual review of biochemistry.

[49]  F. Murad,et al.  Enzymes Synthesizing Guanylate Cyclase-Activating Factors in Endothelial Cells, Neuroblastoma Cells, and Rat Brain , 1991 .

[50]  D. Garbers.  Guanylyl cyclase-linked receptors. , 1991, Pharmacology & therapeutics.

[51]  S. Snyder,et al.  Isolation of nitric oxide synthetase, a calmodulin-requiring enzyme. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[52]  F. Murad.  Modulation of the Guanylate Cyclase -cGMP System by Vasodilators and the Role of Free Radicals as Second Messengers , 1989 .

[53]  F. Murad.  Mechanisms for Hormonal Regulation of the Different Isoforms of Guanylate Cyclase , 1989 .

[54]  D. Goeddel,et al.  The membrane form of guanylate cyclase. , 1988, Cold Spring Harbor symposia on quantitative biology.

[55]  F. Murad,et al.  Effects of nitrovasodilators, endothelium-dependent vasodilators, and atrial peptides on cGMP. , 1988, Cold Spring Harbor symposia on quantitative biology.

[56]  F. Murad,et al.  Endothelium-dependent vasodilator-and nitrovasodilator-induced relaxation may be mediated through cyclic GMP formation and cyclic GMP-dependent protein phosphorylation. , 1983, Transactions of the Association of American Physicians.

[57]  R M Rapoport,et al.  Endothelium-dependent and nitrovasodilator-induced relaxation of vascular smooth muscle: role of cyclic GMP. , 1983, Journal of cyclic nucleotide and protein phosphorylation research.

[58]  F. Murad,et al.  Endothelium-dependent and nitrovasodilator-induced activation of cyclic GMP-dependent protein kinase in rat aorta. , 1983, Journal of cyclic nucleotide and protein phosphorylation research.

[59]  F. Murad,et al.  Purification of soluble guanylate cyclase from rat liver. , 1979, Proceedings of the National Academy of Sciences of the United States of America.

[60]  F. Murad,et al.  Effect of Nitro-Compound Smooth Muscle Relaxants and Other Materials on Cyclic GMP Metabolism , 1979 .

[61]  F. Murad,et al.  Guanylate cyclase: activation by azide, nitro compounds, nitric oxide, and hydroxyl radical and inhibition by hemoglobin and myoglobin. , 1978, Advances in cyclic nucleotide research.

[62]  F. Murad,et al.  2745 – EFFECT OF NITRO-COMPOUND SMOOTH MUSCLE RELAXANTS AND OTHER MATERIALS ON CYCLIC GMP METABOLISM , 1978 .

[63]  P. Greengard.  Cyclic nucleotides, protein phosphorylation, and neuronal function. , 1975, Advances in cyclic nucleotide research.

[64]  F. Murad,et al.  Requirement for a macromolecular factor for sodium azide activation of guanulate cyclase. , 1975, Journal of cyclic nucleotide research.

[65]  Appleman Mm,et al.  Regulation of cyclic nucleotide phosphodiesterase. , 1975, Advances in cyclic nucleotide research.

[66]  White Aa.  Guanylate cyclase activity in heart and lung. , 1975 .